BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22233693)

  • 1. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009.
    Lakatos PL; Golovics PA; David G; Pandur T; Erdelyi Z; Horvath A; Mester G; Balogh M; Szipocs I; Molnar C; Komaromi E; Veres G; Lovasz BD; Szathmari M; Kiss LS; Lakatos L
    Am J Gastroenterol; 2012 Apr; 107(4):579-88. PubMed ID: 22233693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of early immunosuppressive therapy on the rate of resections performed in patients with Chron's disease, in Veszprém county, Hungary, a population-based cohort study].
    Golovics PA; Lakatos PL; Dávid G; Pandur T; Erdélyi Z; Horváth A; Mester G; Balogh M; Szipocs I; Molnár C; Komáromi E; Lovász BD; Szathmári M; Kiss LS; Lakatos L
    Orv Hetil; 2012 Apr; 153(14):541-52. PubMed ID: 22450143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates.
    Ramadas AV; Gunesh S; Thomas GA; Williams GT; Hawthorne AB
    Gut; 2010 Sep; 59(9):1200-6. PubMed ID: 20650924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
    Papay P; Reinisch W; Ho E; Gratzer C; Lissner D; Herkner H; Riss S; Dejaco C; Miehsler W; Vogelsang H; Novacek G
    Am J Gastroenterol; 2010 May; 105(5):1158-64. PubMed ID: 20010925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease.
    Marehbian J; Arrighi HM; Hass S; Tian H; Sandborn WJ
    Am J Gastroenterol; 2009 Oct; 104(10):2524-33. PubMed ID: 19532125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic features of Crohn's disease associated with failure of medical treatment.
    Moran GW; Dubeau MF; Kaplan GG; Yang H; Seow CH; Fedorak RN; Dieleman LA; Barkema HW; Ghosh S; Panaccione R;
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):434-42.e1. PubMed ID: 23978351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and predictors of hospitalization in Crohn's disease in a prospective population-based inception cohort from 2000-2012.
    Golovics PA; Lakatos L; Mandel MD; Lovasz BD; Vegh Z; Kurti Z; Szita I; Kiss LS; Pandur T; Lakatos PL
    World J Gastroenterol; 2015 Jun; 21(23):7272-80. PubMed ID: 26109815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.
    Nørgård B; Pedersen L; Christensen LA; Sørensen HT
    Am J Gastroenterol; 2007 Jul; 102(7):1406-13. PubMed ID: 17437503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
    Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
    Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of pediatric Crohn's disease: a population-based cohort study.
    Vernier-Massouille G; Balde M; Salleron J; Turck D; Dupas JL; Mouterde O; Merle V; Salomez JL; Branche J; Marti R; Lerebours E; Cortot A; Gower-Rousseau C; Colombel JF
    Gastroenterology; 2008 Oct; 135(4):1106-13. PubMed ID: 18692056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis.
    Szamosi T; Banai J; Lakatos L; Czegledi Z; David G; Zsigmond F; Pandur T; Erdelyi Z; Gemela O; Papp M; Papp J; Lakatos PL
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):872-9. PubMed ID: 19648821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of chronic inflammatory bowel diseases].
    Lémann M
    Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT™ Registry.
    Lichtenstein GR; Feagan BG; Cohen RD; Salzberg BA; Diamond RH; Langholff W; Londhe A; Sandborn WJ
    Am J Gastroenterol; 2014 Feb; 109(2):212-23. PubMed ID: 24394749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease.
    Picco MF; Zubiaurre I; Adluni M; Cangemi JR; Shelton D
    Am J Gastroenterol; 2009 Nov; 104(11):2754-9. PubMed ID: 19584832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
    Savarino E; Bodini G; Dulbecco P; Assandri L; Bruzzone L; Mazza F; Frigo AC; Fazio V; Marabotto E; Savarino V
    Am J Gastroenterol; 2013 Nov; 108(11):1731-42. PubMed ID: 24019080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence rates and disease course of paediatric inflammatory bowel diseases in Western Hungary between 1977 and 2011.
    Lovasz BD; Lakatos L; Horvath A; Pandur T; Erdelyi Z; Balogh M; Szipocs I; Vegh Z; Veres G; Müller KE; Golovics PA; Kiss LS; Mandel MD; Lakatos PL
    Dig Liver Dis; 2014 May; 46(5):405-11. PubMed ID: 24495511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    Kim PS; Zlatanic J; Korelitz BI; Gleim GW
    Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of colorectal cancer in Crohn's disease patients with colonic involvement and stenosing disease in a population-based cohort from Hungary.
    Lovasz BD; Lakatos L; Golovics PA; David G; Pandur T; Erdelyi Z; Balogh M; Szita I; Molnar C; Komaromi E; Vegh Z; Mandel MD; Kiss LS; Lakatos PL
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):265-8. PubMed ID: 24078982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for the prevention of postoperative recurrence of Crohn's disease.
    Yamamoto T; Watanabe T
    Colorectal Dis; 2013 Dec; 15(12):1471-80. PubMed ID: 23809911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.